Previous Article | Next Article ![]()
Journal of Virology, July 2000, p. 6006-6014, Vol. 74, No. 13
Laboratory of Infectious Diseases, National Institute of
Allergy and Infectious Diseases, Bethesda, Maryland
20892-07201 and Department of Immunology
and Microbiology, Rush-Presbyterian-St. Luke's Medical Center,
Chicago, Illinois 606122
Received 9 February 2000/Accepted 12 April 2000
The promoters involved in transcription and RNA replication by
respiratory syncytial virus (RSV) were examined by using a plasmid-based minireplicon system. The 3' ends of the genome and antigenome, which, respectively, contain the 44-nucleotide (nt) leader (Le) and 155-nt trailer-complement (TrC) regions, should each
contain a promoter for RNA replication. The 3' genome end also should
have the promoter for transcription. Substitution for the Le with
various lengths of TrC demonstrated that the 3'-terminal 36 nt of TrC
are sufficient for extensive (but not maximal) replication and that
when juxtaposed with a transcription gene-start (GS) signal, this
sequence was also able to direct transcription. It was also shown that
the region of Le immediately preceding the GS signal of the first gene
could be deleted with either no effect or with a slight decrease in
transcription initiation. Thus, the TrC is competent to direct
transcription even though it does not do so in nature, and the partial
sequence identity it shares with the 3' end of the genome likely
represents the important elements of a conserved promoter active in
both replication and transcription. Increasing the length of the
introduced TrC sequence incrementally to 147 nt resulted in a fourfold
increase in replication and a nearly complete inhibition of
transcription. These two effects were unrelated, implying that
transcription and replication are not interconvertible processes
mediated by a common polymerase, but rather are independent processes.
The increase in replication was specific to the TrC sequence, implying
the presence of a nonessential, replication-enhancing
cis-acting element. In contrast, the inhibitory effect on
transcription was due solely to the altered spacing between the 3' end
of the genome and GS signal, which implies that the transcriptase
recognizes the first GS signal as a promoter element. Neither the
enhancement of replication nor the inhibition of transcription was due
to increased base-pairing potential between the 3' and 5' ends. The
relative strengths of the Le and TrC promoters for directing RNA
synthesis were compared and found to be very similar. Thus, these
findings highlighted a high degree of functional similarity between the
RSV antigenomic and genomic promoters, but
provided a further distinction between promoter requirements for
transcription and replication.
Human respiratory syncytial
virus (RSV) is a member of the family Paramyxoviridae
of the order Mononegavirales, the nonsegmented negative-strand RNA viruses (35). The genome of RSV (strain A2) is 15,222 nucleotides (nt) in length and encodes 11 proteins. Three
proteins are associated with the nucleocapsid: the major RNA-binding
nucleocapsid N protein, the P phosphoprotein, and the major polymerase
subunit L (21, 32, 42). The RSV N, P, and L proteins
together with the RNA genome are the virus-specific components required
for RNA replication (19, 43). Processive transcription
requires, in addition, the transcription antitermination protein, M2-1
(11, 15, 20).
In some aspects of transcription and replication, RSV resembles
prototype mononegaviruses such as Sendai virus (SeV) and vesicular stomatitis virus (VSV) (reviewed in references 12,
26, and 39). The genome is tightly bound
by N protein to form the nucleocapsid, which is the template for the
viral polymerase. The 3' and 5' ends of the genome consist of short
extragenic leader (Le) and trailer (Tr) regions, respectively
(29). Genome transcription is initiated at the
genomic promoter located at the 3' (Le) end (13) and
involves a sequential stop-start mechanism in which the polymerase is
guided by conserved cis-acting signals present at the ends
of each gene to produce a series of subgenomic mRNAs (24). The RSV transcription signals are the 10-nt gene start (GS) and 12- to 13-nt gene end (GE) signals found at the beginning and
end, respectively, of each gene (25). It is not known
whether the RSV Le region is transcribed into a short positive-sense Le RNA, comparable to those of VSV and SeV.
In RNA replication, the genome is copied into a complete positive-sense
encapsidated intermediate called the antigenome; hence, the 3'
and 5' ends of the antigenome are the Tr complement (TrC) and
Le complement (LeC), respectively. The antigenome is the
template for the synthesis of progeny genome. In the case of RSV, the
Le and TrC regions are 81% identical for the first 26 nt, after which there is no apparent relatedness (Fig. 1)
(29). This likely represents a conserved promoter at the 3'
end of the genome and antigenome. It might also represent a
conserved encapsidation signal at the 5' end of these molecules,
although as yet there is no evidence for this signal for RSV
(33).
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Analysis of the Genomic and Antigenomic
Promoters of Human Respiratory Syncytial Virus
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (12K):
[in a new window]
FIG. 1.
Sequences of the 3' termini of RSV genomic and
antigenomic RNA (Le and TrC, respectively). The first 52 nt
of the TrC sequence are shown with gaps introduced to maximize sequence
alignment with the Le sequence, and nucleotide assignments that are
identical in Le and TrC are shown in boldface. The last 10 nt of Le are
underlined, the GS signal is italicized, and the transcription
initiation site is indicated with an arrow. Note that the Le contains a
C residue at position 4. Both the C and G assignments have been
identified at this position in biologically derived virus.
The early events in mononegavirus transcription and RNA replication are not well understood. A widely held view is that a common polymerase initiates at a single promoter, copies the Le region, and somehow commits to either stop-start transcription or readthrough replication. The availability of soluble N protein to direct cosynthetic encapsidation of the nascent positive-sense product is thought to switch the polymerase to readthrough replication (4, 23). According to this model, transcription and RNA replication are interconvertible processes. However, an alternative possibility is that transcription and replication are independent processes that involve different versions of the polymerase and/or different cis-acting initiation signals. In this case, transcription need not necessarily initiate at the 3' genomic terminus. In this respect, there is some evidence that transcription can be initiated directly at the GS signal of the first gene of VSV (7).
While it appears that certain features of transcription and replication are shared among the mononegaviruses, RSV has its own distinct features. For example, processive transcription requires an antitermination factor, the M2-1 protein, which is not found in most other mononegaviruses. Two additional proteins, NS1 and M2-2, which exist only for the Pneumovirus genus, have been implicated in regulating RNA synthesis (2, 3, 22). Deletion of the M2-2 gene reduces RNA replication and augments RNA transcription. Unlike other paramyxoviruses, RSV replication does not require the genome nucleotide length to be a multiple of 6 (36). Furthermore, the cis-acting signals involved in initiation of replication and transcription appear to be mostly or entirely confined to the extragenic regions and the first GS signal (10, 24), whereas for other paramyxoviruses, these signals extend into the adjacent genes (30, 38).
The present study investigates the cis-acting sequences involved in RSV transcription and RNA replication and, in particular, examines and compares the genomic and antigenomic promoters contained in the Le and TrC regions, respectively.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
cDNAs. Minigenome plasmids C41, C2, and 2G have been described previously (15, 19, 33). Each encoded minigenome contains in 3'-to-5' order the 44-nt RSV Le, the 10-nt NS1 GS signal, the upstream 29 nt of the nontranslated region of the NS1 gene, a 669-nt negative-sense copy of the chloramphenicol acetyltransferase (CAT) open reading frame (ORF), the last 12 nt of the nontranslated region of the L gene, the 12-nt L GE signal, and the 155-nt Tr region. Minigenome 2G differs in that it contains a C-to-G mutation (negative sense) at position 2 relative to the 5' end of the Tr. Each cDNA is bordered at the 5' end relative to the encoded minigenome by three G residues and the T7 RNA polymerase promoter (the G residues improve efficiency of initiation by the T7 RNA polymerase) and at the 3' end with a self-cleaving ribozyme: the hammerhead ribozyme in C2 and 2G (19) and the hepatitis delta virus ribozyme in C41 (34). Plasmid C4 contains minigenome C2 in the opposite orientation with respect to the ribozyme and T7 RNA polymerase promoter and so encodes a positive-sense miniantigenome. Minigenome plasmids A36 to A147 were prepared by PCR-amplifying portions of the RSV Tr sequence with C41 plasmid as a template. The negative-sense primer contained a portion of the hepatitis delta ribozyme sequence, including an RsrII site, and hybridized to the end of the Tr region. The positive-sense primer contained a BstXI site and hybridized within the Tr region to generate Tr fragments of 36, 57, 77, 97, 117, or 147 nt. The PCR products were digested with RsrII and BstXI and inserted into the RsrII-BstXI window of minigenome C41, which contains an RsrII site within the ribozyme and a naturally occurring BstXI site within the Le (the BstXI recognition sequence spans nt 35 to 46). Plasmids B36 to B147 were constructed by the method of Byrappa et al. (5): minigenome plasmids A36 to A147 were used as templates for PCR amplification by using a positive-sense phosphorylated primer whose 5' end lay 42 nt from the Tr terminus and a negative-sense phosphorylated primer whose 5' end lay at the end of the L GE signal. The PCR product was gel purified and ligated. Plasmids C61, C81, and C101 were prepared by inserting oligonucleotide duplexes into the BstXI site of plasmid C2, resulting in heterologous insertions of 17, 37, or 57 nt. These insertions regenerated the end of the Le such that the heterologous sequence was placed between the Le and the NS1 GS signal. Each insert included a unique AflII site. Minigenome plasmids C121 and C151 were prepared by inserting 20 and 50 nt into the AflII site within C101 by using oligonucleotide duplexes consisting of sequence randomly chosen from the RSV N gene. Plasmids D36 to D97 were generated by using A36 to A97 as templates in a PCR (5), a phosphorylated positive-sense primer whose 5' end lay at the first G residue of the NS1 GS signal, and a phosphorylated negative-sense primer whose 5' end lay at position 34 of the Le. Plasmids E36 to E97 were constructed by transferring the Tr region of plasmid 2G into plasmids A36 to A97 by using NcoI, which restricts within the CAT ORF, and HindIII, which restricts between the plasmid backbone and the T7 RNA promoter. Minigenome plasmid F1 was generated from plasmid C41 by PCR mutagenesis (5) to insert a hammerhead ribozyme (1) and a sequence GGGACGG, which allows optimal transcription by the T7 RNA polymerase, between the Tr and the T7 RNA polymerase promoter. Minigenome F3 was constructed in a similar manner with a version of C41 that contains a G rather than a C at position 4 of the Le (negative sense). Minigenome plasmids F2 and F4 were prepared from F1 and F3, respectively, by using PCR to replace the Tr region with LeC sequence. The LeC sequence contained a G at position 4 relative to the 3' end of the antigenome.
Transfections. Monolayers of HEp-2 cells in six-well dishes were simultaneously infected with 10 PFU (per cell) of vaccinia virus vTF7-3 (provided by Thomas Fuerst and Bernard Moss), which expresses the T7 RNA polymerase (18), and transfected with the following mixture of plasmids per well of a six-well dish: 0.2 µg of minigenome DNA, 0.4 µg of pTM1 N, 0.2 µg of pTM1 P, 0.1 µg of pTM1 M2-1, and 0.1 µg of pTM1 L (Fig. 2 to 7) or 0.2 µg of minigenome DNA, 0.4 µg of pTM1 N, 0.2 µg of pTM1 P, and 0.1 µg of pTM1 L (Fig. 8), as described previously (19). Control transfections lacking L or all support plasmids received pTM1 plasmid with no insert so that the amount of transfected DNA was equivalent in each well. Twenty-four hours later, the transfection-infection mixture was replaced with OptiMem containing 2% fetal bovine serum and actinomycin D (Calbiochem) at 2 µg/ml. The actinomycin D-containing medium was removed after 2 h, replaced with fresh OptiMem containing 2% fetal bovine serum, and incubated for a further 24 h. Each transfection reaction was set up in duplicate; RNA was directly extracted from cells from one of the wells, and the cells in the other well were lysed with nonionic detergent and incubated with micrococcal nuclease (MCN) prior to RNA purification to digest unencapsidated RNA, as described previously (14).
RNA isolation, oligo(dT) chromatography, and Northern blot hybridization. RNA was extracted by dissolving cell pellets or MCN-treated cell lysates in Trizol reagent (Life Technologies) according to the supplier's protocol, except that the RNAs were extracted with phenol-chloroform and ethanol precipitated after the isopropanol precipitation. Oligo(dT) chromatography was performed with an Oligotex mRNA mini kit (Qiagen) according to the manufacturer's instructions, except that the RNA was denatured by being heated to 95°C prior to addition of the Oligotex suspension. RNA representing 1/10 of one well of cells was analyzed by electrophoresis in a 1.5% agarose gel containing 0.44 M formaldehyde, transferred to nitrocellulose (Schleicher & Schuell), and fixed by UV cross-linking (Stratagene). Negative-sense or positive-sense 32P-labelled CAT-specific riboprobe was synthesized by T7 RNA polymerase from XbaI-digested C2 cDNA or NcoI-digested C4 cDNA, respectively and hybridized to the Northern blot in a mixture of 6× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 5× Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), and 200 µg of sheared DNA per ml at 65°C for 12 h. The blots were washed in 2× SSC-0.1% SDS at room temperature for 30 min and then at 65°C for 2 h and then in 0.1× SSC-0.1% SDS at 65°C for 15 to 30 min. The blot shown in Fig. 4D was hybridized with a 5' 32P-labelled, negative-sense, Le-specific oligonucleotide probe (5'-GGTTTATGCAAGTTTGTTGTACGCATTTTTTCCCGT) in a solution of 6× SSC, 5× Denhardt's solution, 0.1% SDS, 0.05% sodium pyrophosphate at 52°C for 12 h. The blot was washed in 6× SSC for 30 min. PhosphorImager analysis was carried out with a PhosphorImager 445 SI (Molecular Dynamics).
Primer extension analysis of RNA. Oligo(dT)-purified or total RNA representing one-third to one-half of a well of cells or 5 pmol of RNA transcribed in vitro from plasmid C4 by T7 RNA polymerase was annealed to an excess of 5' 32P-labelled, negative-sense, CAT-specific oligonucleotide probe (5'-GGGATATATCAACGGTGGTATATCCAGTG) in 1× SuperScript II buffer (Life Technologies) by heating the mixture to 95°C for 5 min and placing it at room temperature for 15 min. One-half of the RNA-DNA hybrid was utilized as a template in a reverse transcriptase reaction using SuperScript II reverse transcriptase (Life Technologies) according to the supplier's reaction conditions, except that the reaction was carried out at 37°C for 1 h. The cDNA was extracted with phenol-chloroform and precipitated with ethanol and resuspended in 20 µl of a mixture of 95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol. Ten microliters of this cDNA was electrophoresed on a 5% LongRanger (J. T. Baker) polyacrylamide gel and analyzed by autoradiography and phosphorimaging. As a molecular length marker, a dideoxy C sequencing reaction was carried out with the same oligonucleotide as a primer and with C41 plasmid as a template for T7 Sequenase (Amersham).
| |
RESULTS |
|---|
|
|
|---|
Effects of replacing Le with TrC.
RNA synthesis from the RSV
genomic and antigenomic promoters was compared by
using a plasmid-based, intracellular system in which a genome analog
(minigenome) containing a CAT reporter gene is coexpressed with
RSV nucleocapsid and polymerase proteins. The RNAs synthesized by the
reconstituted RSV polymerase are detected by Northern blotting.
Minigenome C41 represents the wild-type genome and contains at
its 3' end the first 86 nt of the RSV genome, including the 44-nt Le,
the NS1 GS signal, and the nontranslated region of the NS1 gene, and at
its 5' terminus, the last 179 nt of the genome, including the
nontranslated region of the L gene, the L GE signal, and the 155-nt Tr
(Fig. 2A). To examine the promoter activity of the TrC region, we constructed a series of
minigenomes in which the first 34 nt of Le sequence were
replaced with various lengths of TrC sequence ranging from 36 to 147 nt
(minigenomes A36 to A147). The 10 nt that lie immediately
upstream of the NS1 GS signal were left intact to avoid disruption of
possible cis-acting elements preceding this GS signal (Fig.
2A).
|
TrC nt 77 to 97 enhance replication independently of
increased terminal complementarity.
Increasing the length of TrC
sequence used to replace Le might have affected the pattern of
positive-sense RNA synthesis either directly, as a consequence of its
primary sequence or increased length compared to that of Le, or
indirectly, by increasing the degree of terminal complementarity and
potential interaction between the genome ends, or both. Terminal
complementarity has been shown to affect transcription and replication
by VSV (40, 41). To distinguish between these possibilities,
minigenomes were constructed that were similar to those
described above, but contained only the 5'-proximal 42 nt of Tr
sequence (B series of minigenomes [Fig.
3A]). Thus, these minigenomes
have increasing amounts of TrC sequence at the 3' terminus, but share
the same degree of terminal complementarity.
|
The effect of TrC on RNA replication is independent of its effect
on transcription.
To determine if the effects of increasing TrC
were sequence or spacing dependent, minigenomes were
constructed in which a spacer sequence was inserted at the end of the
Le region, such that the length of the 3' extragenic region was similar
to that in the minigenomes used in Fig. 2 and 3 (C series, Fig.
4A). These minigenomes differ
slightly from those used in the experiments described above, because
their 3' terminus is generated by a hammerhead ribozyme rather than the
hepatitis delta virus ribozyme, a technical point which would not
influence the results. However, so that the minigenome
backbones within the experiment were consistent, minigenome C2
was used as a positive control instead of minigenome C41.
|
The 10 nt of Le that immediately precede the GS signal are not essential for accurate transcription initiation. As described above, TrC sequence juxtaposed to the last 10 nt of Le and the GS signal directed transcription. To examine if the 10 Le nt are necessary for transcription to occur, we compared minigenomes in which they were deleted (minigenomes D36 to D97) to minigenomes A36 to A97.
Minigenomes which contained 57, 77, or 97 nt of TrC sequence yielded similar amounts of mRNA and antigenome, irrespective of the presence of the 10 Le nt (Fig. 5B and C, compare lanes 3, 4, and 5 to lanes 8, 9, and 10). This demonstrated that these nucleotides are not required for transcription or RNA replication. However, minigenomes that contained 36 nt of TrC sequence produced significantly less mRNA and slightly more antigenome if the last 10 nt of Le were deleted, suggesting that this region does play a minor role in regulating transcription and/or replication.
|
|
Comparison of promoter strength of TrC to that of Le.
It was
of interest to directly compare the strengths of the genomic
promoter in Le and the antigenomic promoter contained in
TrC. This could not be done reliably in the preceding experiments because they employed minigenomes which were competent for
amplification by the reconstituted RSV polymerase. Specifically, the
miniantigenome which is produced serves in turn as a template
to produce progeny minigenome. As we have described previously
(14, 33), this amplifies the plasmid-supplied
minigenome template 5- to 50-fold, depending on the efficiency
of reconstituted replication in any particular experiment. Thus, any
mutation which affects the efficiency of antigenome synthesis
can drastically affect the level of minigenome template,
complicating evaluation of mutations. This problem can be overcome by
blocking amplification by introducing one of several point mutations
into the Tr region (33), one example being a C-to-G
substitution at the penultimate nucleotide (Fig.
7A). This mutation does not significantly
affect encapsidation or template activity of the plasmid-supplied
minigenome, but the miniantigenome it encodes is
inactive as a template for the progeny minigenome.
|
Promoter activity of Le under conditions of enhanced terminal
complementarity.
Previously it had been shown that increasing the
complementarity within the terminal 50 nt of VSV augments replication
and inhibits transcription (40, 41). Although the result
shown in Fig. 3 addressed the role of terminal complementarity beyond 42 nt, this experiment did not examine the importance of
complementarity within the terminal 42 nt. To examine this,
minigenome C41 was modified by replacing the Tr region with the
44-nt complement of Le (LeC), creating minigenome F2 (Fig.
8A). This increased the amount of
terminal complementarity from 27 of 44 nt (61%) to 43 of 44 nt (98%),
with the single mismatch being at position 4 (see below). We also
placed a ribozyme between the T7 promoter and the 5' end of the
minigenome so that both ends of the minigenome were
generated by self-cleaving ribozymes, which leave correct ends. This
made it possible to place the T7 promoter in an optimal sequence
context for efficient T7-mediated RNA synthesis and obviated effects on
T7 promoter efficiency due to changes in the minigenome 5' end
(33). This modification precluded the need for nonviral G
residues at the 5' end of the minigenome. A version of C41
containing the second ribozyme was constructed and designated
minigenome F1 (Fig. 8A).
|
| |
DISCUSSION |
|---|
|
|
|---|
The control of transcription and replication is a central, unresolved issue in the molecular biology of mononegaviruses. In this study, we compared the genomic and antigenomic promoters of RSV to distinguish the cis-acting requirements for replication and transcription. The promoter contained within TrC was shown to resemble that of Le in being able to direct efficient transcription in addition to replication, when juxtaposed with a GS signal (Fig. 2, 3, 5, 6, and 7). The two promoters also were essentially identical with regard to promoter strength (Fig. 7). The sequence similarity between Le and TrC lies at the 3' termini, which share 81% nucleotide identity for the first 26 nt, after which there is no significant similarity (Fig. 1). It is likely that the 21 conserved nt include the important elements of a functionally conserved promoter, with the caveat that transcription requires, in addition, a downstream GS signal (24). The remainder of the Le and TrC appeared to have sequences which modified these activities, but were not essential and had an impact that was on the order of only several-fold. In addition, we showed that Le-specific sequence is not required for accurate transcription initiation at the first GS signal (Fig. 6).
These findings differ in some ways from those described for model mononegaviruses. For example, the TrC of SeV can direct transcription (6), as described here for RSV, but that of VSV apparently does not (41). Furthermore, both of these model viruses appear to have Le sequence essential for transcription located immediately before the first GS signal (6, 28, 41), whereas there is no evidence for such a signal here for RSV.
Given the greater intracellular accumulation of genome compared to antigenome in cells infected with this group of viruses, it had been suggested that the antigenomic promoter is substantially more powerful than the genomic promoter. Direct comparison of the strengths of the genomic and antigenomic promoters, in a situation in which slight differences would not be exaggerated by genome amplification, showed that the RSV genomic and antigenomic core promoters directed similar amounts of positive-sense RNA synthesis (Fig. 7). In this experiment, we were comparing TrC with an Le that contained a C residue at position 4. Since there are two naturally occurring assignments at this position, we have also used the 2G minigenome backbone to compare the promoter strengths of these two Le sequences and found that a minigenome containing a C residue synthesizes twofold more antigenome RNA than a minigenome containing a G at this position (M.E.P., R.F., and P.L.C., unpublished observations), an effect that seems small, but apparently increases exponentially under conditions permissive for template amplification.
Increasing the length of inserted TrC sequence increased replication and decreased transcription. The effect on replication could not be duplicated with heterologous, non-TrC sequence (Fig. 4), indicating that it depended on a specific TrC sequence element. This appeared to lie between nt 36 and 97, but was not further defined (Fig. 3). Similarly it has been shown for VSV, SeV, and rabies virus that the primary sequence of the TrC region is more efficient at directing replication than the Le (6, 16, 17, 27, 37). There are several possible mechanisms by which sequences within TrC could enhance replication: (i) expediting polymerase binding to the promoter and/or initiation of RNA synthesis; (ii) promoting encapsidation of the nascent RNA, which could facilitate replication processivity; (iii) stabilizing naked, nascent RNA, which might be important if encapsidation lags behind RNA synthesis.
The downregulatory effect on transcription caused by increasing lengths of TrC sequence was due to the increased length of the 3' extragenic region. This was demonstrated by inserting nonspecific spacer sequence into the Le region; mRNA synthesis decreased significantly as the length of spacer was increased (Fig. 4), similar to the situation seen with increasing length of TrC. This result suggests that efficient transcription depends on appropriate spacing between important cis-acting elements, presumably the 3' element and the first GS signal.
The changes in transcription and replication caused by substituting for Le with TrC sequence could not be attributed to the increasing degree of terminal complementarity, because minigenomes in which terminal complementarity was consistent behaved similarly to minigenomes in which terminal complementarity was increased (compare Fig. 2 and 3). Furthermore, comparison of minigenomes containing Tr or LeC sequence at the 5' terminus indicated that the degree of terminal complementarity had no discernible effect on transcription or replication (Fig. 8). These results are consistent with findings for SeV, which indicated that increasing terminal complementarity did not affect replication (37), but contrast with observations made for VSV (40, 41), which indicated that increasing terminal complementarity augmented replication at the expense of transcription.
In these experiments, as well as others described previously (24, 25), there was no evidence of a direct inverse relationship between transcription and RNA replication, as would be expected if these two processes were in balance (e.g., Fig. 7). Although increasing length of the TrC increased replication and decreased transcription, these effects appeared to be coincidental and unrelated. Previous studies of other mononegaviruses have not clarified whether transcription and replication are competitive; some experiments indicated that the ability of a minigenome to direct transcription was not related to its replication efficiency (6, 28), but other experiments indicated an inverse relationship between the two processes (41). The data presented here suggest that for RSV, transcription and replication are for the most part independent rather than competitive, interconvertible processes. There may be some situations in which transcription efficiency affects replication efficiency and/or vice versa (Fig. 5), but this likely is an effect of two independent processes sharing the same template.
The data presented in this paper suggest the following model for RSV transcription and replication. A single cis-acting element contained within the first 26 nt of the Le is utilized for both transcription and replication initiation. During replication, the polymerase binds to this sequence and initiates RNA synthesis directly at the 3' end of the genome. During transcription, the polymerase contacts the 3' element, but initiates RNA synthesis directly at the first GS signal, possibly by contacting the 3' element and the GS signal simultaneously.
This model of transcription initiation eliminates the requirement for a transcription termination site before the first GS signal and is consistent with our finding that the Le sequence immediately upstream of the NS1 GS signal is not required for accurate transcription initiation. It also accounts for the lack of a direct inverse relationship between transcription and replication. This model also accommodates our previous finding that increasing the intracellular concentration of N protein augments replication without inhibiting transcription (14). It is possible that encapsidation is necessary for replication, at either the initiation or elongation stage, and therefore increasing the intracellular concentration of N protein does enhance replication efficiency (as determined by synthesis of complete antigenome and genome). However, since transcription is a distinct process, mRNA synthesis is unaffected by N protein concentration. If this model is correct, transcription and replication could be mediated by two separate pools of polymerase which have different conformations allowing them to bind the common promoter element at the 3' terminus, but then recognize different initiation sites. This is consistent with evidence that VSV transcription and replication are mediated by two subsets of polymerase, differentiated by posttranslational modification (8, 31).
One important postulate of this model is that the Le 3' terminus contains a common element for initiation of transcription and replication. We are currently testing this proposal by carrying out saturation mutagenesis of the Le region to identify the nucleotide requirements for antigenome and mRNA synthesis.
| |
ACKNOWLEDGMENTS |
|---|
We thank Myron Hill and Ena Camargo for technical assistance; Michael Teng for helpful discussion; and Michael Teng, Christine Krempl, Alison Bermingham, Brian Murphy, and Robert Chanock for critical reviews of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: 7 Center Dr. MSC 0720, Bethesda, MD 20892-0720. Phone: (301) 496-3481. Fax: (301) 496-8312. E-mail: pcollins{at}niaid.nih.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschuler, M. R., R. Tritz, and A. Hampel. 1992. A method for generating transcripts with defined 5' and 3' termini by autocatalytic processing. Gene 122:85-90[CrossRef][Medline]. |
| 2. |
Atreya, P. L.,
M. E. Peeples, and P. L. Collins.
1998.
The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.
J. Virol.
72:1452-1461 |
| 3. |
Bermingham, A., and P. L. Collins.
1999.
The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.
Proc. Natl. Acad. Sci. USA
96:11259-11264 |
| 4. | Blumberg, B. M., M. Leppert, and D. Kolakofsky. 1981. Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell 23:837-845[CrossRef][Medline]. |
| 5. |
Byrappa, S.,
D. K. Gavin, and K. C. Gupta.
1995.
A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase.
Genome Res.
5:404-407 |
| 6. | Calain, P., and L. Roux. 1995. Functional characterisation of the genomic and antigenomic promoters of Sendai virus. Virology 212:163-173[CrossRef][Medline]. |
| 7. | Chuang, J. L., and J. Perrault. 1997. Initiation of vesicular stomatitis virus mutant polR1 transcription internally at the N gene in vitro. J. Virol. 71:1466-1475[Abstract]. |
| 8. | Chuang, J. L., R. L. Jackson, and J. Perrault. 1997. Isolation and characterization of vesicular stomatitis virus polR revertants: polymerase readthrough of the leader-N gene junction is linked to an ATP-dependent function. Virology 229:57-67[CrossRef][Medline]. |
| 9. | Collins, P. L., and G. W. Wertz. 1985. Nucleotide sequences of the 1B and 1C nonstructural protein mRNAs of human respiratory syncytial virus. Virology 143:442-451[CrossRef][Medline]. |
| 10. |
Collins, P. L.,
M. A. Mink, and D. S. Stec.
1991.
Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations of the expression of a foreign reporter gene.
Proc. Natl. Acad. Sci. USA
88:9663-9667 |
| 11. |
Collins, P. L.,
M. G. Hill,
J. Cristina, and H. Grosfeld.
1996.
Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.
Proc. Natl. Acad. Sci. USA
93:81-85 |
| 12. | Collins, P. L., K. McIntosh, and R. M. Chanock. 1996. Respiratory syncytial virus, p. 1313-1351. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Raven Press, New York, N.Y. |
| 13. |
Dickens, L. E.,
P. L. Collins, and G. W. Wertz.
1984.
Transcriptional mapping of human respiratory syncytial virus.
J. Virol.
52:364-369 |
| 14. | Fearns, R., M. E. Peeples, and P. L. Collins. 1997. Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236:188-201[CrossRef][Medline]. |
| 15. |
Fearns, R., and P. L. Collins.
1999.
Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.
J. Virol.
73:5852-5864 |
| 16. | Finke, S., and K.-K. Conzelmann. 1997. Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions. J. Virol. 71:7281-7288[Abstract]. |
| 17. |
Finke, S., and K.-K. Conzelmann.
1999.
Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambisense rabies virus.
J. Virol.
73:3818-3825 |
| 18. |
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126 |
| 19. | Grosfeld, H., M. G. Hill, and P. L. Collins. 1995. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J. Virol. 69:5677-5686[Abstract]. |
| 20. |
Hardy, R. W., and G. W. Wertz.
1998.
The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription.
J. Virol.
72:520-526 |
| 21. | Huang, Y. T., P. L. Collins, and G. W. Wertz. 1985. Characterization of the ten proteins of human respiratory syncytial virus: identification of a fourth envelope associated protein. Virus Res. 2:157-173[CrossRef][Medline]. |
| 22. |
Jin, H.,
X. Cheng,
H. Z. Y. Zhou,
S. Li, and A. Seddiqui.
2000.
Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.
J. Virol.
74:74-82 |
| 23. | Kingsbury, D. W. 1974. The molecular biology of paramyxoviruses. Med. Microbiol. Immunol. 160:73-83[CrossRef][Medline]. |
| 24. |
Kuo, L.,
H. Grosfeld,
J. Cristina,
M. G. Hill, and P. L. Collins.
1996.
Effect of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus.
J. Virol.
70:6892-6901 |
| 25. | Kuo, L., R. Fearns, and P. L. Collins. 1997. Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA. J. Virol. 71:4944-4953[Abstract]. |
| 26. | Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1204. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Raven Press, New York, N.Y. |
| 27. | Li, T., and A. K. Pattnaik. 1997. Replication signals in the genome of vesicular stomatitis virus and its defective interfering particles: identification of a sequence element that enhances DI RNA replication. Virology 232:248-259[CrossRef][Medline]. |
| 28. |
Li, T., and A. K. Pattnaik.
1999.
Overlapping signals for transcription and replication at the 3' terminus of the vesicular stomatitis virus genome.
J. Virol.
73:444-452 |
| 29. | Mink, M. A., D. S. Stec, and P. L. Collins. 1991. Nucleotide sequence of the 3' leader and 5' trailer regions of human respiratory syncytial virus genomic RNA. Virology 185:615-624[CrossRef][Medline]. |
| 30. |
Murphy, S. K., and G. D. Parks.
1999.
RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif.
J. Virol.
73:805-809 |
| 31. | Pattnaik, A. K., L. Hwang, T. Li, N. Englund, M. Mathur, T. Das, and A. K. Banerjee. 1997. Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J. Virol. 71:8167-8175[Abstract]. |
| 32. | Peeples, M., and S. Levine. 1979. Respiratory syncytial virus polypeptides: their location in the virion. Virology 95:137-145[CrossRef][Medline]. |
| 33. |
Peeples, M. E., and P. L. Collins.
2000.
Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.
J. Virol.
74:146-155 |
| 34. | Perrotta, A. T., and M. D. Been. 1991. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature 350:434-436[CrossRef][Medline]. |
| 35. | Pringle, C. R. 1991. The order Mononegavirales. Arch. Virol. 117:137-140[CrossRef][Medline]. |
| 36. |
Samal, S. K., and P. L. Collins.
1996.
RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end.
J. Virol.
70:5075-5082 |
| 37. | Tapparel, C., and L. Roux. 1996. The efficiency of Sendai virus genomic replication: the importance of the RNA primary sequence independent of terminal complementarity. Virology 225:163-171[CrossRef][Medline]. |
| 38. |
Tapparel, C.,
D. Maurice, and L. Roux.
1998.
The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.
J. Virol.
72:3117-3128 |
| 39. | Wagner, R. R., and J. K. Rose. 1996. Rhabdoviridae: the viruses and their replication, p. 1121-1135. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Raven Press, New York, N.Y. |
| 40. |
Wertz, G. W.,
S. Whelan,
A. LeGrone, and L. A. Ball.
1994.
Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA.
Proc. Natl. Acad. Sci. USA
91:8587-8591 |
| 41. |
Whelan, S. P. J., and G. W. Wertz.
1999.
Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication.
J. Virol.
73:297-306 |
| 42. | Wunner, W. H., and C. R. Pringle. 1976. Respiratory syncytial virus proteins. Virology 73:228-243[CrossRef][Medline]. |
| 43. | Yu, Q., R. W. Hardy, and G. W. Wertz. 1995. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RSV virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J. Virol. 69:2412-2419[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»